Argus downgraded shares of Pfizer (NYSE:PFE – Free Report) from a buy rating to a hold rating in a report published on Friday, MarketBeat reports. A number of other research analysts have also recently commented on PFE. TD Cowen cut Pfizer from an outperform rating to a market perform rating and set a $32.00 price […]